Description: CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides research and development services for biotechnology and life sciences technology products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food segments; and offers packing and asset management services. The company was founded in 1999 and is headquartered in Tai Po, Hong Kong.
Home Page: www.ck-lifesciences.com
2 Dai Fu Street
Tai Po,
Hong Kong
Phone:
852 2126 1212
Officers
| Name | Title |
|---|---|
| Mr. Tzar Kuoi Li B.Sc., LLD, LLD (Hon), M.Sc. | Executive Chairman |
| Mr. Hing Lam Kam B.Sc., B.ScE, M.B.A. | President & Executive Director |
| Mr. Edmond Tak Chuen IP B.A., M.Sc. | Senior VP, Chief Investment Officer & Executive Director |
| Dr. Kean Meng Toh MBBS | VP, Chief Scientific Officer & Executive Director |
| Mr. Lance Richard Lee Yuen | VP, CEO & Executive Director |
| Mr. Wun Lam Wong | Chief Financial Officer |
| Mr. Pak To Wu | Chief Operating Officer of Global Operations |
| Ms. Yau Lin Wong | Senior Manager of Human Resources & Administration |
| Ms. Ching Sze Chiu | General Counsel |
| Ms. Sze Mun Ho | Vice President of Corporate Development |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.9172 |
| Price-to-Sales TTM: | 0.0928 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1968 |